High incidence of metabolically active Brown adipose tissue in healthy adult humans: Effects of cold exposure and adiposity
There was a one-month increase of 18.6% in first-time AOM prescribing between December 2024 (when first-time AOMs accounted for 0.34% of all prescriptions) and January 2025 (when first-time AOMs accounted for 0.41% of all prescriptions)
However, clinical trials assessing the efficacy of these techniques exclude the majority of the patient population with red knees, patients with large lesion size, high mechanical demands, older age, inflammation, infection, and other systemic diseases
Novo Nordisk has previously indicated that the acquisition of the three Catalent sites will have a mid-single-digit negative impact on operating profit growth next year
Here is what the research actually says, and what you can do about it